Replicative Senescence of CD8 T Cells: Potential Effects on Cancer Immune Surveillance and Immunotherapy

Overview

Journal Cancer Immunol Immunother

Specialties Allergy & Immunology
Oncology
Pharmacology

Date 2004 Apr 7

PMID 15067431

Citations 15

Authors

Rita B Effros

Affiliations

Soon will be listed here.

Abstract

The process of replicative senescence, which stringently limits the proliferative potential of normal T cells, constitutes a potential problem for cancer immunotherapy. The ability of CD8 T cells to recognize and destroy tumor cells has been well-established, but the requirement for massive, prolonged proliferative T-cell expansion and maintenance of functional integrity poses a significant obstacle to the success of cancer immunotherapy. Cancer immune surveillance may also be compromised by the long-term exposure of T cells to tumor antigens, particularly those of latent viruses, which could drive certain T cells to replicative senescence. This review summarizes the major characteristics of T-cell replicative senescence and raises the possibility that this process has the potential to affect both cancer development and treatment. Experimental strategies aimed at preventing T-cell replicative senescence are discussed in the context of cancer immunotherapy and vaccines.

Citing Articles

TIGIT promotes CD8T cells exhaustion and predicts poor prognosis of colorectal cancer.

Liang R, Zhu X, Lan T, Ding D, Zheng Z, Chen T Cancer Immunol Immunother. 2021; 70(10):2781-2793.

PMID: 33634371 PMC: 10992182. DOI: 10.1007/s00262-021-02886-8.

Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV.

Dalzini A, Petrara M, Ballin G, Zanchetta M, Giaquinto C, de Rossi A J Immunol Res. 2020; 2020:8041616.

PMID: 32509884 PMC: 7246406. DOI: 10.1155/2020/8041616.

Reflections from Peter's First Graduate Student.

Effros R Viral Immunol. 2020; 33(3):129-131.

PMID: 32286175 PMC: 7185358. DOI: 10.1089/vim.2019.0079.

Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.

Zhang P, Wei C, Huang X, Peng R, Yang X, Lu J Mol Cancer. 2019; 18(1):105.

PMID: 31153371 PMC: 6545035. DOI: 10.1186/s12943-019-1031-1.

Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms.

Chiappini E, Bianconi M, Dalzini A, Petrara M, Galli L, Giaquinto C Aging (Albany NY). 2018; 10(11):3610-3625.

PMID: 30418933 PMC: 6286860. DOI: 10.18632/aging.101622.

References

Pawelec G, Schneider E, Wernet P . Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative "helper" T cell clones. J Immunol. 1986; 136(2):402-11. View

Brenner M, Heslop H, Rooney C . Gene and cell transfer for specific immunotherapy. Vox Sang. 1998; 74 Suppl 2:87-90. DOI: 10.1111/j.1423-0410.1998.tb05401.x. View

Israel B, Kenney S . Virally targeted therapies for EBV-associated malignancies. Oncogene. 2003; 22(33):5122-30. DOI: 10.1038/sj.onc.1206548. View

Dagarag M, Ng H, Lubong R, Effros R, Yang O . Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol. 2003; 77(5):3077-83. PMC: 149786. DOI: 10.1128/jvi.77.5.3077-3083.2003. View

Yee C, Riddell S, Greenberg P . Prospects for adoptive T cell therapy. Curr Opin Immunol. 1997; 9(5):702-8. DOI: 10.1016/s0952-7915(97)80052-0. View

Bodnar A, Kim N, Effros R, Chiu C . Mechanism of telomerase induction during T cell activation. Exp Cell Res. 1996; 228(1):58-64. DOI: 10.1006/excr.1996.0299. View

Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson B, Ferguson F . Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol. 2002; 37(2-3):445-53. DOI: 10.1016/s0531-5565(01)00212-1. View

Effros R, Zhu X, WALFORD R . Stress response of senescent T lymphocytes: reduced hsp70 is independent of the proliferative block. J Gerontol. 1994; 49(2):B65-70. DOI: 10.1093/geronj/49.2.b65. View

Shay J, Wright W . Telomerase activity in human cancer. Curr Opin Oncol. 1996; 8(1):66-71. DOI: 10.1097/00001622-199601000-00012. View

10.

Mollet L, Duntze J, Leblond V, Bergeron F, Calvez V, Katlama C . CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol. 1998; 10(3):311-23. DOI: 10.1093/intimm/10.3.311. View

11.

Chakraborty N, Stevens R, Mehrotra S, Laska E, Taxel P, Sporn J . Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation. Cancer Immunol Immunother. 2003; 52(8):497-505. PMC: 11032962. DOI: 10.1007/s00262-003-0377-8. View

12.

Mitchell M . Cancer vaccines, a critical review--Part I. Curr Opin Investig Drugs. 2002; 3(1):140-9. View

13.

Shimizu Y, van Seventer G, Ennis E, Newman W, Horgan K, Shaw S . Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion. J Exp Med. 1992; 175(2):577-82. PMC: 2119108. DOI: 10.1084/jem.175.2.577. View

14.

Effros R, Boucher N, Porter V, Zhu X, Spaulding C, WALFORD R . Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol. 1994; 29(6):601-9. DOI: 10.1016/0531-5565(94)90073-6. View

15.

Champagne P, Ogg G, King A, Knabenhans C, Ellefsen K, Nobile M . Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 2001; 410(6824):106-11. DOI: 10.1038/35065118. View

16.

Hooijberg E, Ruizendaal J, Snijders P, Kueter E, Walboomers J, Spits H . Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol. 2000; 165(8):4239-45. DOI: 10.4049/jimmunol.165.8.4239. View

17.

Schwab R, Szabo P, Manavalan J, Weksler M, Posnett D, Pannetier C . Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol. 1997; 158(9):4493-9. View

18.

Hakansson A, Hakansson L, Gustafsson B, Krysander L, Rettrup B, Ruiter D . Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28. Cancer Immunol Immunother. 2002; 51(9):499-504. PMC: 11034219. DOI: 10.1007/s00262-002-0304-4. View

19.

OReilly R, Small T, Papadopoulos E, Lucas K, LACERDA J, Koulova L . Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol. 1998; 20(3-4):455-91. DOI: 10.1007/BF00838055. View

20.

Posnett D, Edinger J, Manavalan J, Irwin C, Marodon G . Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones. Int Immunol. 1999; 11(2):229-41. DOI: 10.1093/intimm/11.2.229. View